Riskpilot← Back to searchSign inGet full accessVESTFOLD TERAPIRIDNING AS
ASActiveOrg 913599403Opprannveien 126, 3175 RamnesOther social work activities without accommodation n.e.c. · NACE 8899Est. 20146 employees
Revenue 2024
NOK 300K
-39% vs 2023
EBITDA margin
37.3%
+1327% vs 2023
Equity ratio
10.9%
Financial strength
Net profit 2024
NOK 93K
+427% vs 2023
| Revenue | NOK 300K | -39% |
| EBITDA | NOK 112K | +1327% |
| Net profit | NOK 93K | +427% |
| Total assets | NOK 260K | +58% |
| Equity | NOK 28K | +144% |
| Employees | 6 | — |
Legal name
VESTFOLD TERAPIRIDNING AS
Org number
913599403
Legal form
Aksjeselskap
NACE code
8899 · Other social work activities without accommodation n.e.c.
Founded
20. juni 2014
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Salg av terapiridning, helsetjenester, undervisning, veiledning og kursvirksomhet. Kjøp og salg av utstyr knyttet til denne virksomheten, herunder levende dyr og andre produkter som naturlig hører sammen med dette.
Address
Opprannveien 126, 3175 Ramnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 885 | 676 | 474 | 491 | 300 |
| Staff expenses | −434 | −189 | −159 | −83 | −1 |
| EBITDA | −14 | 33 | −75 | −9 | 112 |
| Depreciation & amort. | −30 | −10 | −8 | −20 | −20 |
| EBIT | −43 | 23 | −84 | −29 | 92 |
| Net financials | −0 | 0 | 1 | 1 | 1 |
| Profit before tax | −44 | 23 | −83 | −28 | 93 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −44 | 23 | −83 | −28 | 93 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 275 | 237 | 235 | 165 | 260 |
| Equity | 24 | 47 | −36 | −64 | 28 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 251 | 190 | 271 | 229 | 231 |
| Total debt | 251 | 190 | 271 | 229 | 231 |
EBITDA margin
37.3%
This company
15.8%
Market median
+136% vs market
20202024
Equity ratio
10.9%
This company
38.2%
Market median
-71% vs market
20202024
Return on equity
327.3%
This company
18.4%
Market median
+1679% vs market
20202024
Net profit margin
30.9%
This company
8.1%
Market median
+281% vs market
20202024
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
20202024
Debt / equity
8.19×
This company
0.62×
Market median
-1221% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AK Deputy Member | Deputy Member | 2014 |
ES Deputy Member | Deputy Member | 2014 |
GG Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VESTFOLD TERAPIRIDNING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Kirkeberg | Deputy Member | 0 companies |
| Elsa Storvik Kirkeberg | Deputy Member | 0 companies |
| Gunnar Gjellan | Chief Executive Officer | 0 companies |
| Eva Kirkeberg | Chairman | 0 companies |